purpleDx Pulmonary Disease Smartphone App Set for Release
electronRx announced it will launch purpleDx, a smartphone app for cardiopulmonary assessment, at CES 2025.
Read MorePosted by Chris Wolski | Dec 23, 2024 | Flu & Respiratory Infections |
electronRx announced it will launch purpleDx, a smartphone app for cardiopulmonary assessment, at CES 2025.
Read MorePosted by Andy Lundin | Dec 16, 2024 | Middleware & Software, Misc Equipment |
Sensaphone’s Sentinel and WSG30 systems deliver real-time, cloud-based monitoring for laboratory conditions.
Read MorePosted by Andy Lundin | Dec 13, 2024 | Tuberculosis |
WHO granted prequalification to a tuberculosis molecular diagnostic test that delivers rapid detection of TB and drug resistance.
Read MorePosted by Andy Lundin | Dec 11, 2024 | Diagnostic Technologies |
Researchers developed an optimized pooled testing framework, enabling faster, cost-effective, and accurate infectious disease screening.
Read MorePosted by Andy Lundin | Dec 10, 2024 | Cancer, Molecular Diagnostics |
Researchers identified unique molecular “fingerprints” on ribosomes that can detect early-stage cancers using nanopore sequencing devices.
Read More